Looking to sell Benchling stock or options?
Benchling is a developer of a laboratory collaboration platform that aims to expedite and enhance teamwork in life science research. Benchling's platform offers a range of integrated applications that are designed to speed up R&D processes at all stages. This enables scientists to design, share, and document experiments, and share DNA-sequence data via the cloud. As a result, researchers have the necessary resources to speed up, assess, and predict R&D from discovery to bioprocessing, all from a single platform.
Draper Associates, Tiger Global Management, Franklin Templeton (San Mateo), Rogue Capital, ICONIQ Growth, Elad Gil, Y Combinator, Lone Pine Capital, Ashton Kutcher, Artisanal Ventures, Lux Capital, Spark Capital, Benchmark Capital Holdings, Founders Fund, Andreessen Horowitz, Christopher Golda, Michael Montano, Thrive Capital, Adam Draper, Eight Roads, F-Prime Capital, Foreword, Ensemble Labs, Menlo Ventures, Balaji Srinivasan.
/PRNewswire/ -- Benchling, the R&D platform powering the biotech industry, today announced an expanded collaboration with Moderna. What began with Benchling...
Read moreThe partnership enables Sanofi to fast-track pharmaceutical processes by updating legacy software.
Read moreBenchling announced that Zealand Pharma A/S, a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data.
Read moreBenchling Bioprocess delivers new design, planning, and execution capabilities on a unified platform, to address the evolving requirements of modern process development SAN FRANCISCO, Sept. 19, 2023 /PRNewswire/ -- Benchling announced Benchling Bioprocess, a …
Read moreNew product features include JMP integration, BLAST, and AlphaFold to drive faster decision-making and better data-driven insights as labs scale their R&D SAN FRANCISCO, June 6, 2023 /PRNewswire/ -- Benchling, the R&D Cloud powering the biotechnology industry…
Read moreBenchling partners with Allotrope, backing industry standards and making library of open source industry data converters freely available to the scientific community SAN FRANCISCO, May 16, 2023 /PRNewswire/ -- Benchling, the R&D Cloud powering the biotechnolo…
Read moreThe startup joins a growing number of U.S. firms, including Facebook-parent Meta Platforms Inc, Amazon.com Inc and several startups, to downsize its workforce
Read moreRigorous examination confirms Benchling offers best-in-class security to protect its global biotech customer base SAN FRANCISCO, Jan. 26, 2023 /PRNewswire/ -- Benchling, the R&D Cloud powering the biotechnology industry, announced it has successfully complete…
Read moreBenchling, the R&D Cloud powering the biotechnology industry, announced the appointment of new executive leadership to its engineering and field organizations. These hires come at the same time the company achieved significant financial milestones. In the first half of its fiscal year, Benchling surpassed 1,000 customers and increased subscription revenue 90% year-over-year. Dollar-based net expansion was greater than 150%, indicative of customers rapidly growing their use of the R&D Cloud.
Read more